Towards an understanding of fatigue in Parkinson disease

被引:89
作者
Hagell, P. [1 ,2 ]
Brundin, L. [3 ]
机构
[1] Lund Univ, Dept Hlth Sci, SE-22100 Lund, Sweden
[2] Univ Hosp, Dept Neurol, Lund, Sweden
[3] Lund Univ, Dept Clin Sci, Sect Psychiat, Lund, Sweden
基金
瑞典研究理事会;
关键词
DAYTIME SLEEPINESS; SUBJECTIVE FATIGUE; DOUBLE-BLIND; MODAFINIL; DEPRESSION; DISORDERS; SYMPTOMS; SYSTEM; TRIAL;
D O I
10.1136/jnnp.2008.159772
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To gain an improved understanding of fatigue in Parkinson disease (PD) by exploring possible predictors among a wide range of motor and non-motor aspects of PD. Methods: 118 consecutive PD patients (54% men; mean age 64 years) were assessed regarding fatigue, demographics and a range of non-motor and motor symptoms. Variables significantly associated with fatigue scores in bivariate analyses were used in multiple regression analyses with fatigue as the dependent variable. Results: Fatigue was associated with increasing Hoehn & Yahr stages, specifically the transition from stages I-II to stages III-V. Regression analysis identified five significant independent variables explaining 48% of the variance in fatigue scores: anxiety, depression, lack of motivation, Unified PD Rating Scale (UPDRS) motor score and pain. Gender, age, body mass index, PD duration, motor fluctuations, dyskinesias, symptomatic orthostatism, thought disorder, cognition, drug treatment, sleep quality and daytime sleepiness were not significantly associated with fatigue scores. When considering individual motor symptom clusters instead of the UPDRS motor score, only axial/postural/gait impairment was associated with fatigue. Conclusions: This study found fatigue to be primarily associated with symptoms of depression and anxiety, and with compromised motivation, parkinsonism (particularly axial/ postural/gait impairment) and pain. These results are in agreement with findings in other disorders and imply that fatigue should be considered a separate PD entity differing from, for example, excessive daytime sleepiness. Fatigue may have a distinguished neurobiological background, possibly related to neuroinflammatory mechanisms. This implies that novel treatment options, including anti-inflammatory therapies, could be effective.
引用
收藏
页码:489 / 492
页数:4
相关论文
共 27 条
[1]   Fatigue in patients with Parkinson's disease [J].
Abe, K ;
Takanashi, M ;
Yanagihara, T .
BEHAVIOURAL NEUROLOGY, 2000, 12 (03) :103-106
[2]   Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease [J].
Adler, CH ;
Caviness, JN ;
Hentz, JG ;
Lind, M ;
Tiede, J .
MOVEMENT DISORDERS, 2003, 18 (03) :287-293
[3]   Is fatigue an independent and persistent symptom in patients with Parkinson disease? [J].
Alves, G ;
Wentzel-Larsen, T ;
Larssen, JP .
NEUROLOGY, 2004, 63 (10) :1908-1911
[4]   Fatigue and basal ganglia [J].
Chaudhuri, A ;
Behan, PO .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2000, 179 (1-2) :34-42
[5]   From inflammation to sickness and depression: when the immune system subjugates the brain [J].
Dantzer, Robert ;
O'Connor, Jason C. ;
Freund, Gregory G. ;
Johnson, Rodney W. ;
Kelley, Keith W. .
NATURE REVIEWS NEUROSCIENCE, 2008, 9 (01) :46-57
[6]   Fatigue in Parkinson's disease: a review [J].
Friedman, Joseph H. ;
Brown, Richard G. ;
Comella, Cynthia ;
Garber, Carol E. ;
Krupp, Lauren B. ;
Lou, Jau-Shin ;
Marsh, Laura ;
Nail, Lillian ;
Shulman, Lisa ;
Taylor, C. Barr .
MOVEMENT DISORDERS, 2007, 22 (03) :297-308
[7]   Measuring fatigue in Parkinson's disease:: A psychometric study of two brief generic fatigue questionnaires [J].
Hagell, Peter ;
Hoglund, Arja ;
Reimer, Jan ;
Eriksson, Brita ;
Knutsson, Ingmari ;
Widner, Hakan ;
Cella, David .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2006, 32 (05) :420-432
[8]   Subjective fatigue and subjective sleepiness: two independent consequences of sleep disorders? [J].
Hossain, JL ;
Ahmad, P ;
Reinish, LW ;
Kayumov, L ;
Hossain, NK ;
Shapiro, CM .
JOURNAL OF SLEEP RESEARCH, 2005, 14 (03) :245-253
[9]  
Huyser BA, 1998, ARTHRITIS RHEUM, V41, P2230, DOI 10.1002/1529-0131(199812)41:12<2230::AID-ART19>3.3.CO
[10]  
2-4